A bit of sweetness for GVHD prevention.

Published in: Blood (2015)

In this issue of Blood, Parmar et al report on preclinical data suggesting that use of ex vivo fucosylated third-party human regulatory T cells (Tregs) could be an effective strategy for prevention of graft-versus-host disease (GVHD).

Keyphrases

regulatory t cells
dendritic cells
endothelial cells
allogeneic hematopoietic stem cell transplantation
electronic health record
induced pluripotent stem cells
big data
pluripotent stem cells
cell therapy
acute lymphoblastic leukemia
acute myeloid leukemia